A specific function for phosphatidylinositol 3-kinase α (p85α-p110α) in cell survival and for phosphatidylinositol 3-kinase β (p85α-p110β) in de novo DNA synthesis of human colon carcinoma cells-Reference-Cited by-同舟云学术

A specific function for phosphatidylinositol 3-kinase α (p85α-p110α) in cell survival and for phosphatidylinositol 3-kinase β (p85α-p110β) in de novo DNA synthesis of human colon carcinoma cells

Published:2000-10 Issue:44 Volume:19 Page:5083-5090
ISSN:0950-9232
Container-title:Oncogene
language:en
Short-container-title:Oncogene

Author:

Bénistant Christine,Chapuis H,Roche Serge

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Genetics,Molecular Biology

Link

http://www.nature.com/articles/1203871.pdf

Reference35 articles.

1. Backer JM, Myers Jr MG, Shoelson SE, Chin DJ, Sun XJ, Miralpeix M, Hu P, Margolis B, Skolnik EY and Schlessinger J. . 1992 EMBO J. 11: 3469–3479.

2. Bi L, Okabe I, Bernard DJ, Wynshaw-Boris and Nussbaum RL. . 1999 J. Biol. Chem. 274: 10963–10968.

3. Chang HW, Aoki M, Fruman D, Auger KR, Bellacosa A, Tsichlis PN, Cantley LC, Roberts TM and Vogt PK. . 1997 Science 276: 1848–1850.

4. Christoforidis S, Miaczynska M, Ashman K, Wilm M, Zhao L, Yip SC, Waterfield MD, Backer JM and Zerial M. . 1999 Nat. Cell Biol. 1: 249–252.

5. Deora AA, Win T, Vanhaesebroeck B and Lander HM. . 1998 J. Biol. Chem. 273: 29923–29928.

Cited by 128 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The PI3K-Akt-mTOR and Associated Signaling Pathways as Molecular Drivers of Immune-Mediated Inflammatory Skin Diseases: Update on Therapeutic Strategy Using Natural and Synthetic Compounds;Cells;2023-06-20

2. PI3K/AKT/mTOR Dysregulation and Reprogramming Metabolic Pathways in Renal Cancer: Crosstalk with the VHL/HIF Axis;International Journal of Molecular Sciences;2023-05-07

3. PI3K Inhibition for Squamous Cell Head and Neck Carcinoma;The Cancer Journal;2022-09

4. Oncogenic Signalling of PEAK2 Pseudokinase in Colon Cancer;Cancers;2022-06-16

5. FDA-Approved Small Molecule Compounds as Drugs for Solid Cancers from Early 2011 to the End of 2021;Molecules;2022-03-31